Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

For nearly 15 years, Dennis Burton worked on a project aimed at solving what he calls "one of the most difficult problems in ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.